Term
|
Definition
- Chagas disease
- African sleeping disease
- Leshminiasis
|
|
|
Term
causative agents (diff. in char.) and vector of african sleeping sickness |
|
Definition
- causative agents
- Trypanosoma b. gambiense
- more chronic (mnth-yrs)
- no major animal reservoir
- case detection, tx to elim.
- Trypanosoma b. rhodesiense
- zoonosis: transmitted by antelope, cattle
- kill in period of wks
- target animal
- vector- tsetse fly
|
|
|
Term
stages of African sleeping sickness |
|
Definition
- early stage- asymptomatic (tryps found in blood and lymph nodes)
- late stage: CNS involvement and tryps in CSF
|
|
|
Term
where is african sleeping sickness found |
|
Definition
- exclusively in sub saharin Africa
- gambiense (W. Africa)
- rhodensiense (E. Africa)
Especially seen in areas of civil war: Sudan, DR Congo, Angola |
|
|
Term
|
Definition
- undulating membrane is how the flagella will move it
|
|
|
Term
|
Definition
- tse tse fly introduce organism
- gains access to blood stream and replicate (rhod: weeks, gam: months, yrs)
- enlarge post. cervical lymph nodes
- access to meningnes and cause meningitis
|
|
|
Term
How does T. brucei survive in blood? |
|
Definition
- the organism would appear and disappear in the blood
- VSG switches (so now you make Ab to one variant of VSG but no the other)- antigenic variation
|
|
|
Term
clinical manifestations of HAT |
|
Definition
- gambian
- Winterbottom's cervical adenopathy
- asymp. for months or years
- intermittent fever- Ag variation
- weight loss
- CNS involvement
- diurinal somnolescence with nocturnal insomnia
- constant headache
- behavioral changes
- rhodesian HAT: wks for symptoms
|
|
|
Term
|
Definition
- microscopy
- lymph node aspirates
- blood smear
- nonspecific lab elevation
- ESR
- increase IgG
- increase IgM
- late stage: look at CSF sediment
- anion exchange centrifugation
|
|
|
Term
|
Definition
- suramin for blood borne disease
- melarsoprol for CNS penetration
- very toxic drug basically cause you are arsenic poisoning the protozoa and hoping that happens before you kill the patient
|
|
|
Term
|
Definition
- gambian HAT
- no zoonotic reservoir
- case detection, management
- rhodesian HAT
- cattle zoonotic reservoir
- vector control
- veterinary control
|
|
|
Term
causative agent of Chagas disease |
|
Definition
|
|
Term
epidemiology of Chagas disease |
|
Definition
- mainly in South America
- vector: reduviid bug aka kissing bug
|
|
|
Term
|
Definition
- as kissing bug it feeds on you, it will deposit its feces on your face
- the feces contain the protozoa, and scratching at that area will cause infection
- go into blood and replicate
- predisposition for mycoardial fibers of the heart
|
|
|
Term
clinical syndrome of acute chagas disease |
|
Definition
- chagoma- indurated lesion at site of parasite entry
- Romana's sign (when conjunctiva is port of entry)
- malaise, fever, facial edema
- high parasitemias, lymphocytosis
- severe myocarditis with EKG changes
|
|
|
Term
clinical syndrome of chronic chagas disease |
|
Definition
- cardiomyopathy
- left ventricular aneurysm
- conduction defects
- denervation at the colon and esophagus leads to megacolon and megaesophagus (they are basically not functional)
|
|
|
Term
|
Definition
- acute
- myocarditis in epidemiologic settings
- parasite detection
- parasite cultivation and xenodiagnosis
- T. cruzi IgM
- chronic
- T cruzi specific IgG
- Abbot Labs
- Gulf Labs
- PCR
Above all, you must do blood smear. |
|
|
Term
|
Definition
- antiparasitic drugs limited
- pacemakers
- gamma interferon
- cardiac transplantation (reactivation of acute disease occurs because of post op immunosuppression)
|
|
|
Term
Types of clinical syndromes seen in Leishmaniasis (and epidemiology in one of the clinical syndromes) |
|
Definition
- visceral leishmaniasis
- kala azar (black pigments)
- major cause of morbitity and mortality
- opportunisitic infection in HIV/AIDS
- cutaneous leishmaniasis
- mucocutaneous leishmaniasis
|
|
|
Term
vector of transmission of leishmaniasis |
|
Definition
|
|
Term
visceral leishmaniasis (epidemiology) |
|
Definition
- emerging opportunistic infection among AIDS
- causative agents: L. donoviani (Asia, Africa)
- esp. seen in East Africa
- seen a lot in India, Sudan
- potential reservoir: dogs
|
|
|
Term
clinical features of visceral leishmaniasis (black fever) and what age group is most susceptible |
|
Definition
- majority self resolving
- full blown kala azar
- spiking fever
- weight loss
- hepatosplenomegaly
- pancytopenia
- hypergammaglobinemia
- hyperpigmentation
- children under 5 are most susceptible group
|
|
|
Term
tx visceral leishmaniasis |
|
Definition
can use lipid formulation of amphotericin B (but its very expensive) |
|
|
Term
life cycle of L. donovani |
|
Definition
- organism transmitted by sand fly
- organism will coat itself with C3b complement because it wants to be engulfed by macrophages
- selectively replicate within the macrophage
- accumulates in reticuloendothelial system (spots where there are a lot of macrophages)
|
|
|
Term
dx visceral leishmaniasis (kala azar) |
|
Definition
- fine needle aspiration of spleen
- 90% sensitive
- hemorrhagic complications
- bone marrow aspiration
- intradermal leishmanin skin test
look for macrophages containing amastigotes |
|
|
Term
tx of visceral leishmaniasis |
|
Definition
- pentavalent antimony (SbV)- documentation of cure by symptomatic improvements
- new less toxic alternatives
|
|
|
Term
cutaneous leishmaniasis: clinical manifestations and dx |
|
Definition
- cutaneous manifestations
- develop where parasite inoculate
- wet lesion: pizza like with raised borders overlying purulent exudate
- dry lesion: smaller and covered with crust
- diffuse cutaneous leishmaniasis
- cutaneous nodules and plaques
- more common in HIV/AIDS
- dx- biopsy of findings
|
|
|
Term
Cutaneous leishmaniasis: causative agents in developed and developing world |
|
Definition
- new world
- L. mexicana
- L. amozonesis
- L. brazillensis
- old world
- L major (sub Saharan West Africa, Russia, Iran)
- L. tropica (West China, India, Pakistan, Central Asia, West Chain)
|
|
|